Shilpa Biologicals, the biologics arm of Raichur-based Shilpa Medicare Ltd., has formally activated its antibody–drug conjugate (ADC) drug substance manufacturing facility in Dharwad, India. The plant is currently...
Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...
India's Ministry of Health and Family Welfare has published draft amendments to the Medical Devices Rules, 2017, via G.S.R. 515(E) in the Extraordinary Gazette...
The U.S. Food and Drug Administration (FDA) issued a proposed rule aimed at strengthening oversight of foreign tobacco product manufacturers and blocking illegal products...
Union Home Minister and Minister of Cooperation Shri Amit Shah inaugurated the pilot project for the "PM Family Care Tracker," a groundbreaking integrated monitoring system designed...
The Central Drugs Standard Control Organization (CDSCO) has announced that all applications for Post-Approval Changes in Registration Certificates and Import Licences for Human Vaccines...